Skip to content

My Virtual Dream publishes PLOS study on Nuit Blanche results

“My Virtual Dream” is an innovative and interactive live performance experience of the Virtual Brain technology developed by researchers at Baycrest Health Sciences Centre in partnership with neuroscience experts around the world.

Baycrest Heath Sciences’ “My Virtual Dream,” an innovative and interactive live performance experience at the intersection of science, art and music, is currently touring the installation with appearances in Amsterdam in May and more scheduled for Irvine, CA in October.

MaRS Innovation is working with the Baycrest team to commercialize the technology behind the demonstration, known as the virtual brain.

My Virtual Dream was featured in TechVibes on July 8 and in a PLOS blog published on August 14, 2015.

“The Virtual Dream tour is a ‘living lab’ that engages the public, fuels science, creates art and educates while it entertains,” says Richard Tavener, executive producer of the Virtual Dream tour.

The exhibition and research project was originally mounted in partnership with the University of Toronto, Nuit Blanche 2013, and InteraXon and also made a January 2015 appearance at the Ontario Science Centre.

Participants wear the Muse, a brain-computer interface headset provided by InteraXon, and use focus and mental relaxation states to complete a science game and create a stunning array of visuals and music.

The brain data collected at Nuit Blanche has yielded insights about how the brain learns and a science paper about this massive, one-night neuroscience experiment. The paper, which appeared in the July issue of PLOS One, found that:

Continue Reading

Dr. Raphael Hofstein in Biotechnology Focus: It’s time to declare an end to Canada’s two research solitudes

Dr. Raphael Hofstein
Dr. Raphael Hofstein, president & CEO, MaRS Innovation.

Biotechnology Focus, a compendium of the Canadian life sciences industry, has published a guest column by Dr. Raphael Hofstein, MaRS Innovation’s president & CEO, and Elizabeth Monier-Williams, director of marketing and communications.

The article explores the way research focused on discovery and commercialization are often viewed or positioned as competitors within the funding ecosystem and the need to align their goals:

The time of Canada’s French and English solitudes may be past, as Governor General Michaëlle Jean notably stated when she took office in 2005, but the solitudes of thought concerning how Canada supports basic and commercial research persist.

This thinking is most easily spotted after the government announces a federal budget, triggering a flurry of opinion pieces debating the breakdown for the $2.7 billion Canada spends on research.

Most recently, Jim Balsillie, co-founder of Research in Motion (now BlackBerry Ltd.), wrote for the Globe & Mail about the Canadian need to understand that “geopolitics is at the heart of commercializing ideas,” and create better policies to protect Canadian ideas, including “better
incentives for researchers to spur commercialization,” such as during an academic’s consideration for tenure. Yet, like any business endeavor whose success depends on people, there’s more involved in changing Canada’s approach to commercialization than just policy.

The people must want to change, too.

Continue Reading

MaRS Innovation statement on the 2015 Federal Budget

mi_logo_squareTORONTO, ON (April 23, 2014) — MaRS Innovation congratulates the Federal Government’s deepened commitment to support Canadian research and innovation, particularly in the healthcare sector. In particular, the $42 million over five years dedicated to support the Canadian Centre for Aging and Brain Health Innovation at Baycrest Health Sciences, which includes $32 million in support from the Federal Economic Development Agency for Southern Ontario (FedDev).

Baycrest is a founding member institution of MaRS Innovation.

“As a Baycrest partner and long-time champions of the commercialization potential of its world-class science in brain and geriatric health care, MaRS Innovation welcomes this news,” says Dr. Raphael (Rafi) Hofstein, president and CEO. “We look forward to advancing existing neuroscience projects in partnership with Baycrest, such as The Virtual Brain, and to collaborating on new start-up companies and licenses related to dementia and other neurodegenerative diseases.”

Other promising budget allocations for the innovation sector include:

Continue Reading

Life Sciences Ontario’s statement on the 2015 Ontario Budget

LSO Building Blocks

TORONTO, ON (April 23, 2015) — Life Sciences Ontario (LSO) applauds the government’s continued commitment to supporting life sciences through the Ontario Health Innovation Council and its accompanying $20 million innovation fund, programs to support job creation for Ontario’s highly educated young workforce and a new approach to providing the venture capital needed to support the commercialization of technologies and growth of companies in the life sciences sector.

Specifically, LSO notes the following commitments from the 2015 budget that will help drive innovation in Ontario:

  • Endorsing the Ontario Health Innovation Council report, which will establish a $20 million Health Technology Innovation Fund and appoint a chief innovation strategist to act on the report’s recommendations.
  • Funding the TalentEdge Program, which provides internships for graduate and postgraduate students and is integral to boosting campus-linked industrial research while developing and commercializing the innovative ideas of young researchers.
  • Committing $23.5 million over five years to help establish the Canadian Centre for Aging and Brain Health Innovation Centre at Baycrest Health Sciences, a world leader in cognitive neuroscience, and $25 million over five years to support the recently established Ontario Institute for Regenerative Medicine (OIRM).
Continue Reading

Baycrest’s “My Virtual Dream” brain exhibit at Ontario Science Centre Jan 17-18, 2015

MaRS Innovation is a My Virtual Dream event sponsor and commercialization partner

Baycrest Logo 2015Toronto, ON (January 12, 2015) – Baycrest Health Sciences’ dazzling brain science exhibit from 2013 Scotiabank Nuit Blanche will be on show at the Ontario Science Centre’s BRAINFest, Jan. 17-18.

My Virtual Dream is an innovative and interactive live performance experience at the intersection of science, art and music.  The installation will enable participants to use their brain waves to communicate with each other through an immersive audio and visual expression that will be projected onto video screens.

“Participating at BRAINFest is a great way to share Baycrest’s renowned strengths in cognitive neuroscience in a highly artistic and interactive way with the public,” says Dr. Randy McIntosh, vice-president of Research and Director of Baycrest’s Rotman Research Institute. “Baycrest wishes to thank the Ontario Brain Institute for bringing My Virtual Dream into the Ontario Science Centre and to MaRS Innovation as our key collaborative partner.”

The concept for My Virtual Dream is inspired by an ongoing international project led by Dr. McIntosh and the Rotman to build a virtual, functional brain – a research and diagnostic tool that could one day revolutionize brain healthcare.

The installation, created by Baycrest and the University of Toronto for Nuit Blanche 2013, was a huge hit with fans of the festival. It also represented an extraordinary neuroscience experiment that explored how people can collectively synchronize their brain waves to co-create a multi-sensory environment that merges art, science and technology. In a single night, Rotman researchers collected brain data from over 500 people who signed on to be research subjects.

Continue Reading
Back To Top